| Q36543836 | 5. Mechanisms of disordered granulopoiesis in congenital neutropenia |
| Q34984428 | A Drosophila model of Barth syndrome |
| Q39353974 | A novel function of the human CLS1 in phosphatidylglycerol synthesis and remodeling |
| Q56866762 | AAV-Mediated TAZ Gene Replacement Restores Mitochondrial and Cardioskeletal Function in Barth Syndrome |
| Q61809506 | AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome |
| Q38083725 | Advances in the understanding of Barth syndrome |
| Q28513321 | Agpat6--a novel lipid biosynthetic gene required for triacylglycerol production in mammary epithelium |
| Q28202093 | Ancient ubiquitous protein 1 binds to the conserved membrane-proximal sequence of the cytoplasmic tail of the integrin alpha subunits that plays a crucial role in the inside-out signaling of alpha IIbbeta 3 |
| Q24538743 | Ascospore formation in the yeast Saccharomyces cerevisiae |
| Q28708978 | Bacteria, yeast, worms, and flies: exploiting simple model organisms to investigate human mitochondrial diseases |
| Q59615706 | Barth syndrome |
| Q28248533 | Barth syndrome diagnosed in the subclinical stage of heart failure based on the presence of lipid storage myopathy and isolated noncompaction of the ventricular myocardium |
| Q36594262 | Barth syndrome, a human disorder of cardiolipin metabolism |
| Q27692590 | Barth syndrome. |
| Q36525892 | Cardiac-specific succinate dehydrogenase deficiency in Barth syndrome |
| Q33963761 | Cardiolipin and apoptosis |
| Q28395178 | Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function |
| Q36745013 | Cardiolipin synthesis for the assembly of bacterial and mitochondrial membranes |
| Q35723436 | Cell biology of cardiac mitochondrial phospholipids |
| Q34492639 | Characterization of Bacteroides fragilis hemolysins and regulation and synergistic interactions of HlyA and HlyB. |
| Q24604918 | Characterization of a transgenic short hairpin RNA-induced murine model of Tafazzin deficiency |
| Q40439645 | Characterization of lymphoblast mitochondria from patients with Barth syndrome |
| Q46882304 | Clinicopathologic conference: Barth Syndrome |
| Q33956959 | Coenzyme q and the respiratory chain: coenzyme q pool and mitochondrial supercomplexes |
| Q24306890 | Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography |
| Q28289152 | Complex expression pattern of the Barth syndrome gene product tafazzin in human cell lines and murine tissues |
| Q38230999 | Conduction defects/cardiomyopathies |
| Q85274604 | Costeff syndrome: clinical features and natural history |
| Q40789063 | DGAT2 is a new diacylglycerol acyltransferase gene family: purification, cloning, and expression in insect cells of two polypeptides from Mortierella ramanniana with diacylglycerol acyltransferase activity |
| Q55309132 | Decreasing cytosolic translation is beneficial to yeast and human Tafazzin-deficient cells. |
| Q24290629 | Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome |
| Q40719070 | Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome |
| Q35625960 | Delineating the role of alterations in lipid metabolism to the pathogenesis of inherited skeletal and cardiac muscle disorders: Thematic Review Series: Genetics of Human Lipid Diseases |
| Q38095919 | Emerging roles of cardiolipin remodeling in mitochondrial dysfunction associated with diabetes, obesity, and cardiovascular diseases |
| Q37938707 | Eponym: Barth syndrome |
| Q33873859 | Genetic analysis of the G4.5 gene in families with suspected Barth syndrome |
| Q37332722 | Glycerol-3-phosphate acyltransferases: rate limiting enzymes of triacylglycerol biosynthesis |
| Q35137934 | Identification and characterization of LFD-2, a predicted fringe protein required for membrane integrity during cell fusion in neurospora crassa. |
| Q37048226 | Identification of a Novel De Novo Mutation of the TAZ Gene in a Korean Patient with Barth Syndrome |
| Q38235840 | Inborn errors of metabolism underlying primary immunodeficiencies |
| Q92128149 | Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-TAZ Gene Delivery |
| Q77768830 | Infantile dilated X-linked cardiomyopathy, G4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle |
| Q38803011 | Influence of tissue, diet, and enzymatic remodeling on cardiolipin fatty acyl profile. |
| Q26773169 | Lipid Acyl Chain Remodeling in Yeast |
| Q44679122 | Long-term treatment of Barth syndrome with pantothenic acid: a retrospective study |
| Q41577989 | Loss of tafazzin in yeast leads to increased oxidative stress during respiratory growth |
| Q24535744 | Many roads lead to a broken heart: the genetics of dilated cardiomyopathy |
| Q45245380 | Mis-sesnse mutations in Tafazzin (TAZ) that escort to mild clinical symptoms of Barth syndrome is owed to the minimal inhibitory effect of the mutations on the enzyme function: In-silico evidence |
| Q36812787 | Mitochondria-type GPAT is required for mitochondrial fusion |
| Q35550591 | Mitochondrial dysfunction and β-cell failure in type 2 diabetes mellitus |
| Q27930348 | Mitochondrial mislocalization and altered assembly of a cluster of Barth syndrome mutant tafazzins |
| Q24297605 | Mitochondrial respiratory chain supercomplexes are destabilized in Barth Syndrome patients |
| Q27938526 | Morphogenetic pathway of spore wall assembly in Saccharomyces cerevisiae |
| Q35789155 | Mouse Tafazzin Is Required for Male Germ Cell Meiosis and Spermatogenesis. |
| Q37944537 | New developments on the functions of coenzyme Q in mitochondria |
| Q42089787 | Overexpression of mitochondrial oxodicarboxylate carrier (ODC1) preserves oxidative phosphorylation in a yeast model of Barth syndrome |
| Q92756574 | Plasmalogen loss caused by remodeling deficiency in mitochondria |
| Q41736499 | Predicting functions from protein sequences--where are the bottlenecks? |
| Q24532171 | Proteins of the endoplasmic-reticulum-associated degradation pathway: domain detection and function prediction |
| Q90019833 | Proteolytic Control of Lipid Metabolism |
| Q36555188 | Relevance of mitochondrial genetics and metabolism in cancer development |
| Q57441658 | Rickettsia Lipid A Biosynthesis Utilizes the Late Acyltransferase LpxJ for Secondary Fatty Acid Addition |
| Q36709665 | Seven functional classes of Barth syndrome mutation |
| Q35542041 | Sporulation in the budding yeast Saccharomyces cerevisiae |
| Q40028882 | Structural and functional analyses of Barth syndrome-causing mutations and alternative splicing in the tafazzin acyltransferase domain. |
| Q39022326 | Structural basis for selective recognition of acyl chains by the membrane-associated acyltransferase PatA. |
| Q51737988 | Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency. |
| Q81446954 | TAZ encodes tafazzin, a transacylase essential for cardiolipin formation and central to the etiology of Barth syndrome. |
| Q33655020 | Tafazzin protein expression is associated with tumorigenesis and radiation response in rectal cancer: a study of Swedish clinical trial on preoperative radiotherapy |
| Q36340909 | Tafazzin senses curvature |
| Q27936928 | Taz1, an outer mitochondrial membrane protein, affects stability and assembly of inner membrane protein complexes: implications for Barth Syndrome |
| Q38959423 | The Basis for Acyl Specificity in the Tafazzin Reaction |
| Q39453643 | The cellular and molecular mechanisms for neutropenia in Barth syndrome |
| Q40404400 | The mitochondrial quality control protein Yme1 is necessary to prevent defective mitophagy in a yeast model of Barth syndrome |
| Q26995759 | The role of peroxidation of mitochondrial membrane phospholipids in pancreatic β -cell failure |
| Q35861804 | The yeast acyltransferase Sct1p regulates fatty acid desaturation by competing with the desaturase Ole1p |
| Q34561904 | Ventricular arrhythmia in the X-linked cardiomyopathy Barth syndrome. |
| Q34387809 | X chromosome inactivation in carriers of Barth syndrome |
| Q28139732 | X-linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060) |
| Q78254369 | X-linked cardioskeletal myopathy and neutropenia (Barth syndrome)-MIM 302060 |
| Q27938893 | Ypr140wp, 'the yeast tafazzin', displays a mitochondrial lysophosphatidylcholine (lyso-PC) acyltransferase activity related to triacylglycerol and mitochondrial lipid synthesis |
| Q53640842 | [Pediatric cardiology in the genomic era]. |